SHANGHAI, China, April 24, 2018 -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that members of the senior management team will participate at two upcoming investor conferences. Details of the presentations are as follows:
J.P. Morgan’s Global China Summit
Panel: Innovative Healthcare Panel
Date: Tuesday, May 8, 2018
Location: Beijing, China
Panel Time: 4:00pm CST
Bank of America Merrill Lynch Healthcare Conference
Date: Thursday, May 17, 2018
Location: Las Vegas, Nevada
Presentation Time: 8:00am PST
Individuals may access a live webcast of the Bank of America Merrill Lynch Healthcare Conference presentation on the Zai Lab website at www.zailaboratory.com under "Events & Presentations" in the "Investors" section. A replay of the webcast will be available on this site for 90 days following the live event.
About Zai Lab
Zai Lab (NASDAQ:ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners’ and its own products in order to impact human health worldwide.
Contact:
Zai Lab
Billy Cho
+86 137 6151 2501
[email protected]
Solebury Trout
John Graziano
+1 646 378 2942
[email protected]


U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal
Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance
OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
How Marco Pharma International Preserves German Homeopathic Traditions in America
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement 



